Lv1
38 积分 2022-12-27 加入
Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: Current progress and novel strategies
2天前
已完结
Discovery of Novel Hydrazide-Based HDAC3 Inhibitors as Epigenetic Immunomodulators for Cancer Immunotherapy
1个月前
已完结
Discovery of Highly Potent and Orally Bioavailable Histone Deacetylase 3 Inhibitors as Immunomodulators and Enhancers of DNA-Damage Response in Cancer Therapy
1个月前
已完结
Discovery of Novel and Highly Potent Dual PD-L1/Histone Deacetylase 6 Inhibitors with Favorable Pharmacokinetics for Cancer Immunotherapy
1个月前
已完结
Exploring the potential of histone demethylase inhibition in multi-therapeutic approaches for cancer treatment
1个月前
已完结
Overview of the epigenetic/cytotoxic dual-target inhibitors for cancer therapy
1个月前
已完结
Mechanisms driving the immunoregulatory function of cancer cells
1个月前
已完结
Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity
2个月前
已完结
Discovery of Novel Hydrazide-Based HDAC3 Inhibitors as Epigenetic Immunomodulators for Cancer Immunotherapy
2个月前
已完结
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma
2个月前
已完结
皖公网安备34019202002308
